INDIANAPOLIS, Ind. — A federal award to fund the Indiana Clinical and Translational Sciences Institute validates Indiana’s position as a biomedical research leader, and citizens across Indiana and beyond will benefit, say Hoosier life sciences leaders.
The National Institutes of Health has awarded a five-year grant of $25 million to the IU School of Medicine to fund Indiana CTSI activities at Indiana and Purdue Universities. The NIH created the clinical and translational awards program as a high priority effort to improve the process by which the laboratory discoveries of basic science are transformed into new medical treatments and products – a process called translational research.
Officials at the NIH said the Indiana CTSI is one of the most broadly collaborative of the more than two dozen such programs it has funded to date, with community partners including Clarian Health, Eli Lilly and Co., BioCrossroads, Cook Group, Roche, Wellpoint, the Indiana Economic Development Corp., the Indiana Department of Health and the Marion County Health Department.
“The institute harnesses all of Indiana’s major life sciences research centers into a commonly focused enterprise that will give Indiana’s research scientists many new advantages in finding ways to do their work more effectively and efficiently,” said IU President Michael A. McRobbie. “Over the long term, this will have an enormously positive impact on the state and will make laboratories at both IU and Purdue far more competitive for the major research awards of the future.”
“This partnership creates the only national clinical and translational sciences institute that’s a statewide research laboratory, and the National Institutes of Health acknowledged that,” said France A. Córdova, president of Purdue. “This unique structure means Purdue and Indiana university researchers can address the human health needs of the entire state, especially those in our more rural communities.”
One key to the success of the Indiana CTSI will be its ability to go beyond translating scientific discoveries to treatments and standard health care practices, said Anantha Shekhar, M.D., Ph.D., professor of psychiatry at IU School of Medicine and IU assistant vice president for life sciences, who has been named director of the Indiana CTSI.
“We will build systems that facilitate all levels of research and provide community feedback to researchers. This will enable the researchers to improve and refine the conduct of their science and improve care of their patients. We call it the “translational circle,’ ” Dr. Shekhar said.
Connie Weaver, Ph.D., head of the Department of Foods and Nutrition at Purdue, has been named deputy director of the CTSI at Purdue. Bennett Bertenthal, Ph.D., dean of the IU College of Arts and Sciences, has been named deputy director for the IU Bloomington campus.
D. Craig Brater, M.D., vice president for life sciences of IU and dean of the IU School of Medicine, noted that the institute represents the future of biomedical research.
“The health issues facing us are enormous, the science is complex, and resources must be used carefully. Just as the emphasis on translational science is of vital importance, so are broad-based partnerships and collaborations keys to our success in Indiana. Both are epitomized by the CTSI,” Dr. Brater said.
